The Science Behind helps the pharmaceutical sector meet the challenges of phase 1 clinical trials investigating candidates with central nervous system (CNS) interactions with  the application of technology and techniques to objectively measure brain and central nervous system responses to stimuli or compounds in order to demonstrate a drug effect.

We bring together highly specialised clinical and academic neuroscience, neurology and psychology expertise and combine this with validated methods and access to the technology and hardware to deliver study specific solutions to help clients answer the three critical questions:

Is the drug crossing the blood brain barrier?
Does the drug engage with the right target in the brain?
What is the best dose response?

Our experience with CNS clinical trials means that we can easily adapt to study protocols and timelines and also support trials in healthy and patient cohorts.

Our technical services can be accessed on a study-by-study basis without the need for clients to make significant capital and human resource investments. Thus, giving the freedom to build elements into the study programme as and when required.

We have a collaborative approach and can bring together our external partners to provide a fully integrated CNS target engagement clinical trial service.